Memantine vs Rituximab
Memantine vs Rituximab: Overview
This comparison examines the pharmacological differences between Memantine and Rituximab.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Memantine — 60-80 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Memantine — C12H21N.
Molecular Weight: Memantine — 179.3080 g/mol.
Type: Memantine — Small molecule; Rituximab — Antibody.